Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/209836
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Molecular Diagnosis of Inherited Coagulation and Bleeding Disorders |
Autor: | Bastida, José María; Benito, Rocío; Lozano, María L.; Marín-Quilez, Ana; Janusz, Kamila; Martín-Izquierdo, Marta; Hernandez-Sánchez, Jesus M.; Palma-Barqueros, Verónica; Hernández, Jesús M. CSIC ORCID ; Rivera, José; González-Porras, José R. | Palabras clave: | Molecular diagnosis Inherited platelet disorders Inherited rare bleeding disorders High-throughput sequencing |
Fecha de publicación: | 2019 | Editor: | Thieme | Citación: | Seminars in Thrombosis and Hemostasis 45(07): 695-707 (2019) | Resumen: | Diagnosis of inherited bleeding disorders (IBDs) remains challenging, especially in the case of inherited platelet disorders, due to the heterogeneity of the clinical and laboratory phenotype, the limited specificity of platelet function tests, and the large number of potential culprit genes. Unraveling the underlying molecular defect provides the definitive diagnosis of IBDs, facilitating prognosis and clinical care, which are especially important for severe clinical syndromes and those that may be associated with an increased risk of malignancy. Until recently, Sanger sequencing of candidate genes has been the only method of molecular diagnosis, but this approach is time-consuming and costly and requires phenotype-based identification of any obvious candidate gene(s). Nowadays, high-throughput sequencing (HTS) allows the simultaneous and rapid investigation of multiple genes at a manageable cost. This HTS technology that includes targeted sequencing of prespecified genes, whole-exome sequencing, or whole-genome sequencing, is revolutionizing the genetic diagnosis of human diseases. Through its extensive implementation in research and clinical practice, HTS is rapidly improving the molecular characterization of IBDs. However, despite the availability of this powerful approach, many patients still do not receive a diagnosis. As IBDs are complex and rare diseases, development of more advanced laboratory assays, improvements in bioinformatic pipelines, and the formation of multidisciplinary teams are encouraged to advance our understanding of IBDs. | Versión del editor: | http://dx.doi.org/10.1055/s-0039-1687889 | URI: | http://hdl.handle.net/10261/209836 | DOI: | 10.1055/s-0039-1687889 | ISSN: | 0094-6176 | E-ISSN: | 1098-9064 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
31
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
28
checked on 29-feb-2024
Page view(s)
207
checked on 23-abr-2024
Download(s)
38
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.